Back
Realty Income Corp. Vs. Halozyme Therapeutics, Inc. Industry Stock Comparison
Sell
35
O
Realty Income Corp.
Last Price:
$56.79
Seasonality Move:
1.83%
Buy
65
HALO
Halozyme Therapeutics, Inc.
Last Price:
$69.24
Seasonality Move:
5.49%
Sell
35
Realty Income Corp. (O)
is a Sell
Is Realty Income Corp. a Buy, Sell or Hold?
-
The current Realty Income Corp. [O] share price is $56.69. The Score for O is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
O is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Halozyme Therapeutics, Inc. (HALO)
is a Buy
Is Halozyme Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Halozyme Therapeutics, Inc. [HALO] share price is $68.87. The Score for HALO is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
O Stock Price Chart
What is Realty Income Corp.'s stock price today?
-
The Realty Income Corp. share price today is $56.69Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and O is experiencing slight buying pressure.
HALO Stock Price Chart
What is Halozyme Therapeutics, Inc.'s stock price today?
-
The Halozyme Therapeutics, Inc. share price today is $68.87Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.
O Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 45.95 | Sell |
| Chaikin Money Flow: | 1307589 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.51 - 57.81) | Sell |
| Bollinger Bands (100): | (56.99 - 59.67) | Sell |
HALO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 58.98 | Buy |
| Chaikin Money Flow: | 516593 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.07 - 70.31) | Buy |
| Bollinger Bands (100): | (64.7 - 73.66) | Sell |
O Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.78 | Sell |
| 20-day SMA: | 57.28 | Sell |
| 50-day SMA: | 57.64 | Sell |
| 200-day SMA: | 57.52 | Sell |
| 8-day EMA: | 56.76 | Sell |
| 20-day EMA: | 57.05 | Sell |
| 50-day EMA: | 57.52 | Sell |
| 200-day EMA: | 57.61 | Sell |
HALO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 67.06 | Buy |
| 20-day SMA: | 65.42 | Buy |
| 50-day SMA: | 67.19 | Buy |
| 200-day SMA: | 63.54 | Buy |
| 8-day EMA: | 67.24 | Buy |
| 20-day EMA: | 66.58 | Buy |
| 50-day EMA: | 67.18 | Buy |
| 200-day EMA: | 63.87 | Buy |
Realty Income Corp. Earnings Growth & O Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.25 per share.
Halozyme Therapeutics, Inc. Earnings Growth & HALO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.13 per share, and an increase next year of $1.88 per share.
Realty Income Corp. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Halozyme Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||